Core Insights - The establishment of multiple brain-computer interface (BCI) clinical research centers in Shanxi marks a significant acceleration in the research and application of BCI technology in the region [1] - BCI technology is gaining global attention as a new form of human-computer interaction, aiming to create a connection between the brain and external devices for collaborative interaction between biological and machine intelligence [1] Group 1: Clinical Applications - Shanxi Provincial People's Hospital successfully utilized BCI technology in a surgery for a patient with a high-grade glioma, allowing for real-time monitoring and mapping of brain function, which led to maximal safe tumor removal while preserving motor function [2] - Similar successful surgeries were reported at Shanxi Medical University First Hospital, where a domestic BCI system was used to provide a visual brain function map during surgery for a rare deep brain tumor, resulting in complete tumor removal without damaging neural function [5] Group 2: Neurological Treatment Innovations - The combination of BCI and neural modulation offers new hope for patients with difficult neurological conditions, such as a patient suffering from obsessive-compulsive disorder who underwent deep brain stimulation, leading to significant improvement in her condition [6][8] - A new generation of intelligent, perceivable brain pacemakers has been implanted in patients with consciousness disorders, enabling two-way communication with the brain by both sending and receiving signals [8] Group 3: Interdisciplinary Collaboration - Shanxi is exploring the integration of BCI with traditional Chinese medicine, particularly acupuncture, to enhance rehabilitation outcomes for patients with motor impairments [9] - The development of BCI technology relies on interdisciplinary collaboration, with Shanxi medical institutions actively partnering with universities and research institutes to foster innovation [9] - Challenges such as implant rejection and signal instability in clinical applications are being addressed through the establishment of industry standards and collaborative efforts between capital and policy [9]